Literature DB >> 34238818

Patch Testing With Tocopherol and Tocopherol Acetate: The North American Contact Dermatitis Group Experience, 2001 to 2016.

Erin M Warshaw, Jenna L Ruggiero, Joel G DeKoven1, Jonathan I Silverberg2, Howard I Maibach3, James S Taylor4, Amber R Atwater5, Kathryn A Zug6, Denis Sasseville7, Joseph F Fowler8, Anthony F Fransway9, Melanie D Pratt10, Donald V Belsito11, Vincent A DeLeo12, Margo J Reeder13.   

Abstract

BACKGROUND: Vitamin E (tocopherol) a naturally occurring mixture of antioxidants commonly used in topical skin care products, may cause allergic contact dermatitis.
OBJECTIVE: The aim of this study was to characterize positive patch test reactions to tocopherol and tocopherol acetate.
METHODS: This is a retrospective analysis of North American Contact Dermatitis Group patch test data to tocopherols (dl-α-tocopherol 100% and/or dl-α-tocopherol acetate 100%) from 2001 to 2016.
RESULTS: Of the 38,699 patients patch tested to tocopherol and/or tocopherol acetate, 349 (0.9%) had positive reactions; of these, 87.6% were currently relevant. Most (51.4%) were weak (+) and/or not related to occupation (99.1%). Compared with tocopherol-negative patients, tocopherol-positive individuals were more likely to be female (72.5% vs 67.2%, P = 0.0355), have a final primary diagnosis of allergic contact dermatitis (74.2% vs 52.6%, P < 0.0001), and have dermatitis in a scattered generalized distribution (23.8% vs 18.2%, P = 0.0072); they were also less likely to have hand involvement (16.6% vs 22.3%, P = 0.0064). The most common source of tocopherol was personal care products, especially moisturizers.
CONCLUSIONS: Positive patch test reactions to tocopherols were relatively rare given their widespread use. When positive, current clinical relevance was high. Tocopherol-positive patients were more likely to be female and presented with dermatitis on the face or in a scattered generalized pattern.
Copyright © 2021 American Contact Dermatitis Society. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34238818     DOI: 10.1097/DER.0000000000000706

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  1 in total

1.  Real-World Evidence of an Emollient Device for Atopic and Contact Dermatitis in Pediatric to Adult Patients - Data from a Post-Marketing Surveillance.

Authors:  Adelaide Ann Hebert
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.